November 12
We had the honor to host
Prof. Ana Rita Grosso, from FCT NOVA, who was talking about
‘Decoding Transcriptome Dysregulation: Biomarkers and Implications for Human Health’.
Short Bio
Ana Rita Grosso gathered a Biology degree (FCUL, 2002), followed by a MSc in Bioinformatics (FCUL-IGC, 2006). Her multi-omics expertise in biomedical research was accomplished by gathering a PhD in Biomedical Sciences (iMM/FMUL, 2010), where she unveiled the existence of splicing-factors expression signatures responsible by the tissue-specific regulation of alternative splicing. In 2018, Ana Rita Grosso moved to NOVA School of Science and Technology (FCT-NOVA) and Applied Molecular Biosciences Unit (UCIBIO) to foster her scientific independence and consolidate her research group: Computational Multi-Omics. Her main mission is to decipher pathological conditions using multi-omics approaches, identifying molecular events to be further used as biomarkers and therapeutic targets.
Highlighting, she has been unveiling (epi)genome/transcriptome alterations that affects tumor evolution and metastasis development. More recently she has been awarded a La Caixa Research Health Project as a consortium to study the cell of origin and identify early diagnostics of pancreatic ductal adenocarcinoma. Additionally, given the importance of big data in biological and biomedical fields, she has been putting a large effort into training young and senior researchers to integrate diverse datasets and decipher complex biological data.